Page last updated: 2024-11-04

tegafur and Intestinal Neoplasms

tegafur has been researched along with Intestinal Neoplasms in 15 studies

Intestinal Neoplasms: Tumors or cancer of the INTESTINES.

Research Excerpts

ExcerptRelevanceReference
"In a prospective, multi-centre, randomized study of 109 patients with metastatic gastro-intestinal adenocarcinomas the response rate, survival time and side-effects of two drug combinations, carmustin +5-fluorouracil and carmustin + ftorafur, were compared (same carmustin dosage in both groups)."5.04[A prospective multi-centre study of the response of metastatic gastrointestinal tumours (author's transl)]. ( Arnold, H; Drings, P; Geldmacher, J; Hartwich, G; Kredel, L; Mayer, M; Neidhardt, B; Queisser, W; Rösch, W; Schaefer, J; von Oldershausen, HF; Wahrendorf, J, 1979)
"Paclitaxel was given intravenously on days 1, 8, and 15, starting with a dose of 40 mg m-2 day-1."2.72Phase I/II study of S-1 combined with paclitaxel in patients with unresectable and/or recurrent advanced gastric cancer. ( Aihara, R; Asao, T; Haga, N; Kamiyama, Y; Kuwano, H; Mochiki, E; Nakabayashi, T; Nakamura, J; Ohno, T; Ohsawa, H; Ojima, H; Takeuchi, K, 2006)
"Fluorouracil has been used for a long time, remission rates reported range from 0% to 80%."2.36[Chemotherapy of gastrointestinal tumors (review of the literature)]. ( Mayr, AC, 1978)
"As there is no standard treatment for advanced gastric cancer refractory to first-line chemotherapy, the feasibility of S-1 plus weekly docetaxel combined with concurrent radiotherapy was evaluated."1.35Feasibility study of S-1 plus weekly docetaxel combined with concurrent radiotherapy in advanced gastric cancer refractory to first-line chemotherapy. ( Fujitani, K; Hirao, M; Kurokawa, Y; Tsujinaka, T; Yamasaki, H; Yoshida, K, 2009)
"Forty patients with gastric cancer and 30 patients with colon cancer were administered FT-207 prior to the operation."1.26[Tissue concentration of 5-FU following pre-operative administration of FT-207]. ( Fukao, K; Ishikawa, A; Iwasaki, Y; Nagoshi, K; Okamura, T; Orii, K; Ozaki, A; Sarashina, H; Takase, Y; Takeshima, T; Todoroki, T, 1982)

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19907 (46.67)18.7374
1990's0 (0.00)18.2507
2000's5 (33.33)29.6817
2010's3 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Takayoshi, K1
Kusaba, H1
Uenomachi, M1
Mitsugi, K1
Makiyama, C1
Makiyama, A1
Uchino, K1
Shirakawa, T1
Shibata, Y1
Shinohara, Y1
Inadomi, K1
Tsuchihashi, K1
Arita, S1
Ariyama, H1
Esaki, T1
Akashi, K1
Baba, E1
Fujitani, K1
Tsujinaka, T1
Yamasaki, H1
Hirao, M1
Yoshida, K1
Kurokawa, Y1
Aoki, Y1
Kameda, A1
Miyahara, E1
Funakoshi, M1
Okubo, K1
Yoshioka, S1
Asukai, K1
Hata, T1
Nakanishi, M1
Maekawa, T1
Hama, N1
Kashiwazaki, M1
Taniguchi, M1
Tsujie, M1
Konishi, M1
Yano, K1
Fujimoto, T1
Kotake, M1
Murakami, N1
Bandou, H1
Morita, K1
Koizumi, H1
Yoshino, H1
Tawaraya, K1
Ishiguro, K1
Kinoshita, S1
Yamada, T1
Ishizone, S1
Maruta, F1
Saito, H1
Koide, N1
Sugiyama, A1
Nakayama, J1
Miyagawa, S1
Mochiki, E1
Ohno, T1
Kamiyama, Y1
Aihara, R1
Haga, N1
Ojima, H1
Nakamura, J1
Ohsawa, H1
Nakabayashi, T1
Takeuchi, K1
Asao, T1
Kuwano, H1
Takayama, T1
Sato, Y1
Sagawa, T1
Okamoto, T1
Nagashima, H1
Takahashi, Y1
Ohnuma, H1
Kuroiwa, G1
Miyanishi, K1
Takimoto, R1
Matsunaga, T1
Kato, J1
Yamaguchi, K1
Hirata, K1
Niitsu, Y1
Davis, HL1
Sarashina, H1
Ozaki, A1
Okamura, T1
Fukao, K1
Takase, Y1
Takeshima, T1
Todoroki, T1
Ishikawa, A1
Orii, K1
Nagoshi, K1
Iwasaki, Y1
Okuda, M1
Teramoto, T1
Yoshida, H1
Sato, K1
Ushijima, Y1
Uematsu, Y1
Mayr, AC1
Sokova, OI1
Volgareva, GM1
Sawai, K1
Sonoda, Y1
Ohkuma, S1
Misawa, S1
Takino, T1
Queisser, W1
Schaefer, J1
Arnold, H1
Drings, P1
Geldmacher, J1
Hartwich, G1
Kredel, L1
Mayer, M1
Neidhardt, B1
von Oldershausen, HF1
Rösch, W1
Wahrendorf, J1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Phase I Study of S-1 in Combination With Radiotherapy in Locally Advanced or Recurrent Gastric Cancer[NCT01291407]Phase 127 participants (Actual)Interventional2010-11-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for tegafur and Intestinal Neoplasms

ArticleYear
[Chemotherapy of gastrointestinal tumors (review of the literature)].
    Onkologie, 1978, Volume: 1, Issue:6

    Topics: Ancitabine; Carcinoma, Hepatocellular; Colonic Neoplasms; Doxorubicin; Drug Therapy, Combination; Fl

1978

Trials

4 trials available for tegafur and Intestinal Neoplasms

ArticleYear
Phase I/II study of S-1 combined with paclitaxel in patients with unresectable and/or recurrent advanced gastric cancer.
    British journal of cancer, 2006, Dec-18, Volume: 95, Issue:12

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Drug Combinations;

2006
Phase I study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer.
    British journal of cancer, 2007, Oct-08, Volume: 97, Issue:7

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Combinations; Femal

2007
Chemotherapy of large bowel cancer.
    Cancer, 1982, Dec-01, Volume: 50, Issue:11 Suppl

    Topics: Antineoplastic Agents; Clinical Trials as Topic; Drug Therapy, Combination; Floxuridine; Fluorouraci

1982
[A prospective multi-centre study of the response of metastatic gastrointestinal tumours (author's transl)].
    Deutsche medizinische Wochenschrift (1946), 1979, Aug-31, Volume: 104, Issue:35

    Topics: Adenocarcinoma; Carmustine; Fluorouracil; Gastrointestinal Neoplasms; Humans; Intestinal Neoplasms;

1979

Other Studies

10 other studies available for tegafur and Intestinal Neoplasms

ArticleYear
Suggestion of added value by bevacizumab to chemotherapy in patients with unresectable or recurrent small bowel cancer.
    Cancer chemotherapy and pharmacology, 2017, Volume: 80, Issue:2

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Beva

2017
Feasibility study of S-1 plus weekly docetaxel combined with concurrent radiotherapy in advanced gastric cancer refractory to first-line chemotherapy.
    Anticancer research, 2009, Volume: 29, Issue:8

    Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Doc

2009
[A patient with small intestinal cancer and extensive lymph node metastasis who responded to S-1].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2010, Volume: 37, Issue:5

    Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Drug Combinations; Endosc

2010
[A case report of primary adenocarcinoma of small intestine].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2010, Volume: 37, Issue:12

    Topics: Adenocarcinoma; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized;

2010
[A case of primary small intestinal cancer accompanied by virchow lymph node metastasis undergoing TS-1 treatment].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:12

    Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Drug Administration Schedule; Drug Combinatio

2005
Efficacy of S-1 for patients with peritoneal metastasis of gastric cancer.
    Chemotherapy, 2006, Volume: 52, Issue:6

    Topics: Adult; Aged; Antimetabolites, Antineoplastic; Biomarkers, Tumor; Dihydrouracil Dehydrogenase (NADP);

2006
[Tissue concentration of 5-FU following pre-operative administration of FT-207].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1982, Volume: 9, Issue:7

    Topics: Female; Fluorouracil; Humans; Intestinal Neoplasms; Intestine, Large; Lymph Nodes; Male; Middle Aged

1982
[Clinical study of serum and tissue concentrations of FT-207 and 5-FU in patients with cancer of the large intestine following preoperative application of FT-207 suppositories].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1982, Volume: 9, Issue:9

    Topics: Adult; Aged; Biological Assay; Female; Fluorouracil; Humans; Intestinal Neoplasms; Intestine, Large;

1982
[Action of ftorafur and 5-fluorouracil on the chromosomes of normal and tumorous cells in vivo].
    Voprosy onkologii, 1977, Volume: 23, Issue:2

    Topics: Animals; Bone Marrow; Bone Marrow Cells; Chromosomes; Cricetinae; Dose-Response Relationship, Drug;

1977
[A combined immuno-chemotherapy with futraful and picibanil for advanced cancer (author's transl)].
    Nihon Gan Chiryo Gakkai shi, 1977, Sep-20, Volume: 12, Issue:3

    Topics: Aged; Biological Products; Drug Therapy, Combination; Female; Fluorouracil; Humans; Intestinal Neopl

1977